Novo Nordisk A/S NONOF
40.20 USD +1.30 +3.34%
As of Nov 2, 9:37 AM ET
34.00 52-week range 64.75
- YTD
- -21.25%
- 1 year
- -17.99%
- Open
- 40.20
- Prev close
- 38.90
- Mkt cap
- 177.31B
- Vol
- 107
- Avg vol
- 122.31K
- EPS
- 4.09
- P/E
- 9.83
More statistics
- Low
- 40.20
- High
- 40.20
- Earnings
- Nov 4, 2026
MAX chart
Chart tools
Chart is warming up
The all-time price history for NONOF has not been loaded yet. Try again in a moment.
Altman Z-Score
3.76 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 3
- P/B 1
P/E 14.1×
P/S 4.7×
P/B 7.4×
P/FCF 24.5×
EV/EBITDA 10.4×
EV/Sales 5.0×
FCF Yield 4.1%
Gross Margin 80.3%
Operating Margin 43.7%
Net Margin 33.1%
ROE 52.8%
ROIC 31.2%
ROA 18.9%
Revenue 6.2%
Operating Income 5.0%
EPS (diluted) 1.5%
Free Cash Flow -15.5%
Current Ratio 0.8×
Quick Ratio 0.6×
Debt / Equity 0.7×
Net Debt / EBITDA 0.7×
Interest Coverage 32.0×
Dividend Yield 3.6%
Payout Ratio 50.5%
Annual · latest fiscal year ends 2025-12-31